Gastroenterologists and GI practices in 2026 serve the colonoscopy screening and surveillance population that forms the dominant procedural volume for the endoscopy suite — the average-risk adults at age 45 beginning colorectal cancer screening, the patients with prior adenoma and family history requiring earlier and more frequent surveillance colonoscopy, and the symptomatic patients with rectal bleeding, iron deficiency anemia, and change in bowel habits requiring diagnostic colonoscopy for the procedural GI care that endoscopy suite scheduling dominates, the inflammatory bowel disease patients — Crohn's disease and ulcerative colitis — who require the ongoing IBD management with biologic therapy, infusion treatment, and colonoscopic surveillance that the IBD disease management specialist delivers through the longitudinal care relationship that chronic IBD requires, the patients with upper GI symptoms — GERD, dyspepsia, dysphagia, and upper GI bleeding — requiring the EGD and upper endoscopy that upper GI diagnosis and therapeutic endoscopy provides for the esophageal, gastric, and duodenal pathology that the GI specialist evaluates, the complex biliary and pancreatic patients requiring ERCP, EUS, and advanced endoscopic procedures for the interventional endoscopy that biliary stone management, pancreatic evaluation, and endoscopic stenting requires from the therapeutic endoscopy specialist, and the functional GI disorder patients — IBS, functional dyspepsia, and SIBO — who require the diagnostic evaluation, breath testing, and treatment coordination that functional GI management provides for the GI symptom burden that functional disorders create without the organic pathology that endoscopy evaluates. The US gastroenterology market generates $24.8 billion in 2026 — in a GI healthcare environment where colorectal cancer screening mandates at age 45 have expanded the colonoscopy-eligible population, where biologic therapy has transformed IBD management, and where the growing non-alcoholic fatty liver disease population has created hepatology-GI overlap services. GI-specific EHR systems alongside endoscopy scheduling and insurance platforms provide the infrastructure that virtual assistants use to coordinate the procedure, insurance, IBD treatment, and billing workflows that gastroenterology practice operations require.
The 2026 GI practice landscape reflects the colonoscopy scheduling and prep instruction complexity creating the patient communication demand from GI practices managing the pre-colonoscopy dietary restriction, prep prescription, and arrival instruction that colonoscopy preparation requires from organized patient communication, the biologic and infusion therapy authorization management requirement creating the insurance coordination demand from IBD practices managing step therapy requirements, prior authorization, and infusion center scheduling for the biologic agents that IBD treatment requires, and the colon cancer screening recall management requirement creating the population health demand from GI practices managing the adenoma surveillance recall system that colonoscopy interval guidelines create for the screening and surveillance program — creating the procedure preparation and biologic authorization coordination complexity that systematic virtual assistant support enables GI practices to manage without endoscopic expertise consumed by administrative coordination.
Gastroenterologist and GI Practice VA Functions
Colonoscopy scheduling and prep coordination: Managing the primary procedural revenue workflow — managing colonoscopy screening and surveillance scheduling with endoscopy suite block time, prep prescription coordination, and dietary restriction instruction delivery for the colonoscopy preparation that procedure quality requires from properly prepared patients, coordinating insurance authorization for colonoscopy with screening versus diagnostic indication determination and payer-specific authorization for the reimbursement that correctly coded colonoscopy requires, managing post-colonoscopy follow-up scheduling with surveillance interval based on polyp findings for the ongoing surveillance program that adenoma management requires, and maintaining the colonoscopy quality that the GI practice's primary procedure revenue — where organized colonoscopy scheduling and prep coordination creating the clean procedure and billing accuracy that colonoscopy program economics require — demands for the colonoscopy management that screening coordination produces.
IBD management and biologic therapy coordination: Supporting the chronic disease market workflow — managing inflammatory bowel disease patient visit scheduling with GI physician for the regular IBD follow-up that biologic treatment monitoring and disease activity assessment requires, coordinating biologic therapy prior authorization — Humira, Stelara, Entyvio, and Remicade — with insurance step therapy documentation, failure of prior treatment, and annual reauthorization for the biologic coverage that IBD treatment access requires from insurance authorization, managing infusion center scheduling for IV biologic therapy with infusion center coordination and patient preparation for the infusion appointments that IV biologic administration requires, and maintaining the IBD coordination quality that the GI practice's chronic disease program — where organized biologic authorization and infusion scheduling creating the treatment adherence that IBD outcomes depend on — requires for the IBD management that biologic coordination produces.
EGD, ERCP, and advanced endoscopy scheduling: Managing the procedural diversity workflow — coordinating upper endoscopy (EGD) scheduling for upper GI symptoms with endoscopy suite scheduling and anesthesia coordination for the upper GI procedure that esophageal and gastric evaluation requires, managing ERCP and advanced endoscopy scheduling for biliary and pancreatic procedures with endoscopy suite, anesthesia, and fluoroscopy coordination for the complex therapeutic endoscopy that specialized training requires, coordinating capsule endoscopy scheduling for small bowel evaluation with capsule preparation, swallowing assessment, and video review for the small bowel imaging that capsule endoscopy provides for the small intestine that standard endoscopy cannot reach, and maintaining the advanced endoscopy quality that the GI practice's procedural scope — where organized advanced procedure scheduling creating the comprehensive GI service that tertiary and complex GI patients require — demands for the advanced endoscopy management that ERCP coordination produces.
Colon cancer screening recall and population health: Supporting the preventive health market workflow — managing screening colonoscopy recall program with age-appropriate outreach for patients reaching age 45 and patients due for surveillance colonoscopy for the organized recall that colorectal cancer screening population health requires, coordinating stool-based testing (FIT, Cologuard) for patients choosing non-invasive colorectal screening with test kit ordering, result notification, and colonoscopy referral for positive results for the alternative screening pathway that population health requires from the patients who decline colonoscopy, managing family history-based screening coordination for patients with Lynch syndrome and familial adenomatous polyposis with genetic counseling referral and accelerated screening protocol for the hereditary CRC risk that specialized surveillance requires, and maintaining the screening quality that the GI practice's population health mission — where organized CRC screening recall creating the prevention program that colorectal cancer mortality reduction requires — requires for the recall management that population health coordination produces.
Motility testing and functional GI coordination: Supporting the diagnostic services workflow — managing GI motility testing scheduling — esophageal manometry, anorectal manometry, and hydrogen breath testing — with procedure preparation instruction and referral for the functional GI evaluation that motility disorders require from specialized testing, coordinating SIBO breath testing and result coordination for patients with suspected small intestinal bacterial overgrowth with test kit delivery, result interpretation, and treatment protocol for the functional GI management that SIBO treatment requires, managing functional GI disorder patient education and behavioral referral with Rome IV-based treatment coordination and psychology referral for the biopsychosocial approach that functional GI management requires, and maintaining the functional GI quality that the GI practice's comprehensive diagnostic program — where organized motility testing and functional GI management creating the complete GI service that complex GI patients require — demands for the motility management that functional coordination produces.
Hepatology and billing coordination: Supporting the liver disease and revenue operations workflow — managing fatty liver disease evaluation and NAFLD/NASH staging coordination with fibroscan scheduling and hepatology follow-up for the growing liver disease population that metabolic liver disease creates for GI practices with hepatology expertise, preparing GI billing with endoscopy codes 45378-45399 for colonoscopy, 43239-43259 for upper endoscopy, procedure codes for ERCP and capsule endoscopy, and E&M codes with GI diagnoses for accurate gastroenterology claim submission, and maintaining the billing quality that the GI practice's financial operations — where accurate GI procedure and E&M billing creating the revenue timing that endoscopy suite, physician compensation, and practice overhead require — demands for the hepatology management that billing coordination produces.
Gastroenterologist and GI Practice Business Economics
For a gastroenterology practice with annual revenue of $2.8 million:
- Annual colonoscopy and endoscopy procedure revenue: $1,680,000 (primary procedure revenue)
- IBD management and biologic therapy program: $560,000 additional annual revenue
- Advanced endoscopy and ERCP program: $280,000 additional annual revenue
- Hepatology and fatty liver disease program: $168,000 additional annual revenue
- Functional GI and motility testing program: $112,000 additional annual revenue
- GI practice VA (part-time): $600–$1,200/month
- Annual net revenue impact: $60,000–$90,000
Virtual Assistant VA's gastroenterologist and GI practice support services provide trained gastroenterology and healthcare administration industry VAs experienced in colonoscopy scheduling and prep coordination, IBD management and biologic therapy authorization, ERCP and advanced endoscopy scheduling, colon cancer screening recall management, motility testing and functional GI coordination, and gastroenterology billing — enabling board-certified gastroenterologists to maximize endoscopic and clinical expertise without prep coordination and biologic authorization consuming physician time that colonoscopy interpretation, IBD management, and interventional endoscopy depend on.
Sources:
- ACG — American College of Gastroenterology Clinical Practice Standards and Market Data 2025
- AGA — American Gastroenterological Association GI Market Intelligence 2025
- ASGE — American Society for Gastrointestinal Endoscopy Endoscopy Standards 2025
- IBISWorld — Offices of Gastroenterologists in the US Industry Report 2025